Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors
On 28 May 2026, Frances Health Ministry confirmed that Wegovy and Mounjaro would be covered by the French national health insurance system from 15 June 2026, making France the first country in the European Union to reimburse GLP-1 receptor agonists for obesity
These medications may include: Isocarboxazid, Marplan, phenelzine (Nardil, Nardelzine) tranylcypromine (Parnate, Sicoton), Deprenyl, selegiline hydrochloride, 5 HTP, Amitriptyline, Prozac, Wellbutrin, Bupropion, Buropion HCL, Fluoxetin, EFFEXOR XR, etc
This inflammatory response can disrupt neurological, endocrine, and immune functions, creating a complex and persistent illness
Comprehensive Approach At Tower Urology, we recognize that sexual health is a multifaceted aspect of overall well-being